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Abstract
Long non-coding RNAs (lncRNAs) have been attracting immense research interests. The relevance of lncRNAs in
biological and physiological as well as in pathological processes has increased along with the understanding of
their various regulatory mechanisms. Abundant studies have indicated that lncRNAs are involved in the differentiation,
proliferation, activation, and initiation of apoptosis in different cell types. However, most studies about the regulating
biology of lncRNAs are currently focused on cancer cells. This review is focused on the widely unexplored role of
lncRNAs in the cell fate of myeloid cells. In this review, we summarize recent studies that have confirmed lncRNAs to
be essential in the development of myeloid cells under normal and pathological conditions.




Circulating blood cells are all derived from hematopoietic
stem cells (HSCs), and there have been at least two alter-
native patterns describing the hierarchical hematopoiesis.
Multi-potential progenitors (MPPs) derived from HSCs
give rise to common myeloid progenitors (CMPs) and
common lymphocyte progenitors (CLPs). CMPs de-
velop into granulocyte-macrophage progenitors (GMPs),
which are the sources of granulocytes, monocytes, and
megakaryocyte-erythroid progenitors (MEPs) that can give
rise to erythrocytes and megakaryocytes. On the other
hand, CLPs differentiate into immune cells, such as T cells,
B cells, dendritic cells (DC), and NK cells. Another pattern
of hematopoiesis differs by the involvement of intermedi-
ate lymphoid-primed multi-potential progenitors (LMPPs)
that can differentiate into GMPs and CMPs [1].
During the process of CMPs differentiating into differ-
ent lineages, protein molecules, such as growth factors,
cytokines, and transcription factors (TFs), which label
the cell path and participate up to the destiny, comprise
the complicated regulatory network [1–12]. Furthermore,
non-coding RNA (ncRNA), an additional regulation factor,
has joined the regulatory network of myeloid cell develop-
ment. Recently, regulatory ncRNAs have been further
divided into small ncRNAs and emerging long ncRNAs
[13–17]. This review is focused on regulatory long non-
coding RNAs (lncRNAs) in myeloid cells.
LncRNAs
Expression and regulation of lncRNAs
With the development of gene tiling arrays and tran-
scriptome studies, it has been suggested that only 2 % of
the human genome is transcribed and translated into
proteins, while nearly 90 % is transcribed into ncRNAs
[18]. According to the length of the transcript, ncRNAs
are divided into small ncRNAs (<200 nt), such as micro-
RNAs, and long ncRNAs (>200 nt). Initially recognized
as “transcriptional noise” in previous RNA sequence
studies, lncRNAs are now characterized as functional
RNA elements with features of shorter length, contain-
ing fewer exons, and expressed at lower levels compared
to messenger RNAs (mRNAs) [19–21]. Like for mRNAs,
lncRNAs are transcribed by RNA polymerase II. Process-
ing of lncRNAs involves 3′ poly(A) tailing and 5′-end cap-
ping as well as splicing. LncRNAs have small open reading
frames without any protein-coding potential but can
sometimes be associated with ribosomes in the cytoplasm,
suggesting an additional role in mRNA metabolism [1]. As
* Correspondence: sjwjs@ujs.edu.cn
†Equal contributors
1Department of Laboratory Medicine, The Affiliated People’s Hospital, Jiangsu
University, Zhenjiang 212002, China
2Institute of Laboratory Medicine, Jiangsu Key Laboratory of Laboratory
Medicine, School of Medicine, Jiangsu University, Zhenjiang 212013, China
© 2016 The Author(s). Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0
International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and
reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to
the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver
(http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
Tian et al. Journal of Hematology & Oncology  (2016) 9:99 
DOI 10.1186/s13045-016-0333-7
of now, over 23,000 human lncRNA genes have been
found and are mostly expressed in a cell-, tissue-, or devel-
opmental stage-specific manner. Currently, based on the
localization of lncRNAs to protein-coding mRNAs,
lncRNAs are classified into long intergenic ncRNAs
(lincRNAs), enhancer RNAs (eRNAs), antisense
lncRNAs, intronic lncRNAs, and transcribed pseudo-
gene lncRNAs [19]. However, in light of the accumulat-
ing information on sequencing data and the function of
lncRNAs, these arbitrary definitions will need to be
redefined.
The expression of lncRNAs can be regulated. As por-
trayed above, lncRNAs show tissue-, cell-, and develop-
mental stage-specific expression and are differently
expressed under physiological or pathological conditions,
which indicate that these transcripts can be regulated.
This regulation of lncRNAs can occur at the transcrip-
tional level. For example, the expression of intronic
lncRNAs derived from intronic sequences is usually linked
with host gene expression. However, the expression of
lincRNAs is promoter-dependent. Additionally, lncRNAs
can also be mediated post-transcriptionally based on their
different stability. Stability of lncRNAs is associated with
their location, splicing, and final subcellular position. In a
recent work by Ayupe et al., global analysis of the stability
of lncRNAs mapping to intragenic regions of the human
genome showed that antisense lncRNAs are significantly
more stable than mRNAs, whereas intronic lncRNAs
comprise a more heterogeneous class that consist of
both stable and unstable transcripts. In mice, it has also
been demonstrated that lincRNAs are more stable com-
pared with intronic lncRNAs in mouse neuronal cells.
Additionally, the stability of spliced lncRNAs is much
more than non-spliced lncRNAs, and the half-life of
lncRNAs in the cytoplasm is longer than lncRNAs lo-
calized in the nucleus [22]. Thus, altering the stability
of lncRNAs can modulate their functions. MicroRNA
let-7i has been recently reported to interact with HOX
antisense intergenic RNA (HOTAIR), which is an anti-
sense lncRNA transcribed from the HOX locus, and
decrease HOTAIR expression. However, HOTAIR is
stabilized when let-7i or Argonaute 2 (AGO2) is sup-
pressed, while it is destabilized by let-7i. Meanwhile,
HOTAIR is degraded when human antigen R (HuR)
promotes the interaction of let-7i-AGO2 with
HOTAIR. In cells with suppressed levels of HuR,
HOTAIR is stable and accumulates, which contributes
to a scaffold for E3 ubiquitin ligases and their respect-
ive ubiquitination substrates [23].
Regulatory mechanisms of lncRNAs
The regulatory mechanisms of lncRNAs are diverse.
LncRNAs are capable of interacting with RNA as well
as DNA and proteins which attach lncRNAs with
various molecular functions transcriptionally and post-
transcriptionally. Nuclear lncRNAs can recruit chromatin-
modification factors to suppress or activate different loci
so as to regulate gene expression epigenetically [24–28].
LncRNAs can also assemble transcriptional activators or
repressors to mediate gene transcription. In addition
to regulating gene expression, several lncRNAs in the
nucleus have been demonstrated to be essential for
organizing distinct nuclear structures [29–33]. At the
post-transcriptional level, lncRNAs regulate gene
expression by mediating translation and enhancing the
stability of partially complementary mRNAs. Additionally,
lncRNAs can also interfere with RNA-binding proteins to
influence splicing and translation as well as regulate the
activity and location of the proteins. Finally, lncRNAs can
act as a sponge for endogenous microRNAs (miRNAs)
[1, 19]. The detailed regulatory mechanisms of lncRNAs
are listed in Fig. 1.
Accumulating evidence has indicated that lncRNAs
are crucial regulators of the development, differentiation,
and proliferation of multiple cells. However, the majority
of studies about lncRNAs regulating cell biology are
focused on their effect on various cancer cells, while
their importance during the development of myeloid
cells is also worthy of attention and is the topic of this
review.
LncRNAs in erythrocytes and megakaryocytes
The expression of lncRNAs is different under physio-
logical and pathological conditions, indicating that they
may play crucial biological functions. Over 400 putative
lncRNAs have been identified during mouse erythropoiesis
by an RNA-seq analysis. Thus, lncRNAs play an important
role during erythropoiesis. A recent study, by using RNA-
seq, has identified 1109 polyA+ lncRNAs in murine mega-
karyocytes, erythroblasts, and megakaryocyte-erythroid
precursors, in which most erythro-megakaryocytic
lncRNAs (~75 %) are transcribed from promoters and
the other 25 % from enhancers. The following analysis
indicated that a majority of these lncRNAs are regu-
lated by crucial TFs, such as GATA1 and TAL1. While
these erythroid lncRNAs show dramatic conservation in
different mouse strains, only 15 % of mouse lncRNAs are
expressed in the human. An RNAi assay was performed
on 21 abundant lncRNAs in mouse erythroid precursors
and 7 lncRNAs, including Erytha, Ggnbp2os, Bloodlinc,
Galont, Redrum, Lincred1, and Scarletltr, knockdown
blocked erythroid maturation [34].
LincRNA-EPS
LincRNA-erythroid pro-survival (EPS) is a PolII tran-
script located in the nucleus with the length of 2531 nt
and contains four exons and three introns in mouse
Ter119+ cells. LincRNA-EPS is highly and specifically
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expressed in terminally differentiating erythroblasts. It
has been demonstrated that lincRNA-EPS has a potent
anti-apoptotic activity because knockdown of lincRNA-EPS
resulted in apoptosis during the terminal differentiation of
erythroid cells and blocked the proliferation of erythroid
progenitors. Meanwhile, overexpression of lincRNA-EPS
can prevent erythroid progenitor cells from undergoing
apoptosis caused by Epo deprivation. To confirm which
part of linRNA-EPS mediates the apoptosis of erythroid
cells, a structure-functional analysis was performed in
which different regions of lincRNA-EPS were truncated
from the 5′- to 3′-end and then transduced into Lin− fetal
liver cells. Interestingly, lincRNA-EPS with 5′ truncation
can still suppress apoptosis whereas lincRNA-EPS with 3′
truncation loses this anti-apoptosis activity. Thus, lincRNA-
EPS possesses its anti-apoptotic activity via the 500-nt
sequence at the 3′-end. This modulation of apoptosis
of erythroid progenitors by lincRNA-EPS is partly
through the inhibition of Pycard expression, which is
capable of encoding the protein to activate caspases
during apoptosis [35–37]. Nevertheless, the specific
mechanism is still left to be uncovered.
Shlnc-EC6
Erythroid enucleation is important for the differentiation
of mammalian erythrocytes, as excluding the nucleus from
red cells allows for a higher concentration of hemoglobin
in the blood. Shlnc-EC6 is a lncRNA involved in erythroid
differentiation. The work of Wang et al. has demonstrated
that shlnc-EC6 knockdown in erythroid progenitor and
hematopoietic stem cells (FLEPHSCs) purified from mouse
fetal liver is capable of apparently inhibiting erythroid
enucleation. It is also confirmed that shlnc-EC6 sup-
presses Rac1 expression by directly binding the 3′UTR
of Rac1 mRNA. Thus, shlnc-EC6 knockdown results
in increased expression of Rac1 and the up-regulated
activation of downstream PIP5K which leads to the in-
hibition of enucleation in cultured mouse fetal eryth-
roblasts. This finding indicates that shlnc-EC6 acts as
a post-transcriptional regulator to modulate mouse
Fig. 1 The regulatory mechanisms of lncRNAs located in nucleus and cytoplasm. a RNP component. b Epigenetic regulation. c TF docay.
d Modulation of translation, splicing, and degradation. e MicroRNA sponge. f Regulating the activation of molecular
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erythropoiesis through the Rac1/PIP5K signaling path-
way [38].
AlncRNA-EC7
It has been shown that the alncRNA-EC7 locus in fetal
erythroblasts is in a 6.9-kb region of widespread
H3K4me1 and H3K27Ac markings centered around a
5.2-kb region of open chromatin bound by RNA Pol II,
GATA1, TAL1, and KLF1, hallmarks of a large enhancer.
At this site, bidirectionally transcribed long RNAs are
spliced and polyadenylated to RNAs crossing shorter re-
gions concentrating in the poly(A)− fraction. AlncRNA-
EC7 is located in the nucleus and its enhancer site is
conserved in humans. Additionally, alncRNA-EC7 is an
enhancer of SLC4A1, the coding gene of BAND3, which
is the major anion exchanger of the erythrocyte mem-
brane and a mutation of which can lead to hemolytic
anemias. Knockdown of alncRNA-EC7 from the enhan-
cer leads to significantly decreased expression of neigh-
boring BAND3. Thus, consistent to the co-expression
between alncRNA-EC7 and BAND3, alncRNA-EC7 is
capable of enhancing the expression of BAND3 in cis.
Mapping of long-range chromatin interactions associ-
ated with CCCTC-binding factor (CTCF) and RNA Pol
II in K562 cells reveals chromatin looping between the
enhancer site and the BAND3 promoter-proximal region.
Taken together, alncRNA-EC7 mediates erythropoiesis
partly by regulating enhancer looping to activate the
BAND3 locus [39, 40].
MONC and MIR100HG
LincRNAs MONC and MIR100HG, which are mainly
localized in the nucleus, are highly expressed in acute
megakaryoblastic leukemia (AMKL) blasts. The expression
of these two transcripts is correlated with corresponding
miR-99a/100~125b clusters. An ShRNA-induced loss-of-
function study suggests MONC or MIR100HG knock-
down inhibits leukemic growth of AMKL cell lines and
cells from primary patient samples. In the following inves-
tigation, a lentiviral lncRNA vector was used to ectopically
express lincRNAs without perturbing their secondary
structure. The results suggested that ectopic MONC ex-
pression in cord blood (CB) CD34+-HSPCs leads to the
expansion of immature erythroid precursors and a de-
crease of granulocytic precursors. These results reveal that
MONC interferes with hematopoietic lineage decisions
and enhances the proliferation of immature erythroid
progenitor cells [41].
LncRNAs in granulocytes
Granulocytes are essential for host defense against in-
vading pathogens. Augmentation of neutrophil function
is beneficial for many pathologic conditions. Here, we
summarize the regulation of lncRNAs in the development
and function of granulocytes and their regulatory
mechanisms.
HOTAIR
In the human genome, there are four HOX clusters,
HOXA, HOXB, HOXC, and HOXD. These four HOX
clusters are probably derived from a single ancestral
cluster and are conserved regulators of embryonic pat-
terning and development [42, 43]. HOXA and HOXB
have appeared as the key transcriptional regulators in
hematopoiesis [44, 45]. For example, HOXA9 and
HOXA10 expressed by mature neutrophils can mediate
the transcription of genes associated with the phagocytic
function of neutrophils [46–48]. Additionally, HOX
genes also promote the pathogenesis of acute leukemia
and the self-renewal ability of leukemia stem cells [49].
It is indicated that, in the intergenic region of human
HOX genes, lincRNAs, which are demonstrated to be
direct regulators of cellular functions, show much more
transcription activity than microRNAs, such as miRNA-
10 and miRNA-196 [50, 51]. Among these lincRNAs,
HOTAIR is the first to be defined.
HOTAIR (Hox transcript antisense intergenic RNA) is
a lincRNA with a length of 2158 nt. Although it is lo-
cated in the HOXC gene cluster, HOTAIR can modulate
the remote HOXD gene cluster and a network of discrete
non-HOX gene loci by recruiting elements of the histone-
modifying PRC2 and LSD1 complex [52–54]. However, a
majority of previous studies about HOTAIR, which has
been indicated as a negative prognostic marker, are fo-
cused on its role in the cell biology of various cancer cells
and little is known about the regulation of HOTAIR in
myeloid cells. Recently, the expression of HOTAIR has
been demonstrated to be significantly up-regulated in
AML-de novo patients compared to AML-CR patients
and normal controls, and the higher level of HOTAIR in
AML patients is positively correlated with the NCCN
high-risk group. In addition, HOTAIR knockdown is cap-
able of inhibiting the proliferation of AML cells [55].
HOTAIRM1
In addition to HOTAIR, HOTAIRM1 (HOX antisense
intergenic RNA myeloid 1) is indicated to be one of the
three other lincRNAs that exist in the intergenetic re-
gion of HOX gene clusters. HOTAIRM1, transcribed by
RNA polymerase II, is located between the human
HOXA1 and HOXA2 genes, and its expression is in-
creased during granulocytic differentiation. HOTAIRM1,
which shows myeloid-specific expression, is transcribed
antisense to HOXA genes and originates from the
same CpG island that embeds the start of HOXA1. In
the process of induced granulocytic differentiation,
HOTAIRM1 has been shown to be up-regulated and
the most prominently expressed intergenic transcript.
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During retinoic acid (RA)-induced granulocytic differenti-
ation of NB4 cells, the up-regulation of HOTAIRM1 is
based on the expression of myeloid cell development fac-
tors targeted by RA signaling. Knockdown of HOTAIRM1
significantly inhibits the expression of HOXA1 and
HOXA4 and blunts induction of transcripts for the mye-
loid differentiation genes, such as CD11b and CD18, in
the process of RA-induced granulocytic differentiation.
However, HOTAIRM1 knockdown does not impact the
more remote HOXA genes. These findings suggest that
HOTAIRM1 plays a role in myelopoiesis through modula-
tion of gene expression in the HOXA cluster [50]. The fol-
lowing work of Zhang et al. demonstrated a potential
mechanism in which HOTAIRM1 influences the all trans
retinoid acid (ATRA)-induced granulocytic differentiation.
They find that knockdown of HOTAIRM1 apparently
delays morphological granulocytic maturation during
ATRA-induced granulocytic differentiation of NB4 cells
and significantly increases the proliferation of immature
cells at the G1/S phase transition during ATRA-induced
cell cycle arrest. Along with resistance to arrest of cell
cycle progression, HOTAIRM1 knockdown alters ATRA-
induced changes in CD11c and CD49d expression. The
coupling of cell cycle progression with temporal dynamics
in the expression patterns of these integrin genes suggests
a regulated switch to control the transit from the pro-
liferative phase to granulocytic maturation. Furthermore,
ITGAX is among a small number of genes showing per-
turbation in transcript levels upon HOTAIRM1 knock-
down even without ATRA treatment, suggesting a direct
regulatory pathway [56]. These results indicate that
HOTAIRM1 provides a regulatory link in myeloid matur-
ation by modulating integrin-controlled cell cycle progres-
sion at the gene expression level. Additionally, in our own
research about lncRNA, it is suggested that HOTAIRM1
is associated with the immunosuppression of granulocytic
myeloid-derived suppressor cells (G-MDSCs) in lung
cancer patients. All of these facts indicate the import-
ance of HOTAIRM1 in regulating the cell biology of
granulocytes.
Additionally, in ATRA-induced differentiation of acute
promyelocytic leukemia (APL) cells, it has been revealed
that PU.1 constitutively binds to the regulatory region of
HOTAIRM1, which leads to the transactivation of the
regulatory region of HOTAIRM1. Further analysis sug-
gests that two PU.1 motifs located around +1100 bp
downstream of the transcriptional start site of the
HOTAIRM1 promoter are responsible for the PU.1-in-
duced transactivation. Furthermore, ATRA-induced
HOTAIRM1 is PU.1-dependent, and overexpression of
PU.1 significantly increased HOTAIRM1 levels. Addition-
ally, HOTAIRM1 expression is decreased in APL cells,
which is attributed to the reduced PU.1 expression rather
than the repression by PML-RARα via direct binding [57].
NEAT1
Nuclear paraspeckle assembly transcript 1 (NEAT1), which
is a nuclear-restricted long ncRNA, has two isoforms:
3.7-kb NEAT1-1 and 23-kb NEAT1-2. NEAT1 has re-
cently been identified as a crucial component of a sub-
nuclear structure named the paraspeckle, which has been
shown to regulate gene expression through retaining
mRNA for editing in the nucleus. It has also been sug-
gested that NEAT1 controls several biological processes
including cellular differentiation [58, 59]. In APL, an aber-
rant chromosomal translocation that fuses a portion of the
promyelocytic leukemia (PML) gene with the retinoic acid
receptor α (RARα) gene and subsequent expression of the
PML-RARα oncoprotein causes a differentiation blockade
at the promyelocytic differentiation stage. It is confirmed
that the expression of NEAT1, which consists of NEAT1-1
and NEAT1-2, is dramatically decreased in PBMCs of
APL patients compared to normal granulocytes. This
down-regulation of NEAT1 has been demonstrated to be
caused by PML-RARα and can be restored by ATRA.
However, when NEAT1 expression is blocked, ATRA
cannot continue to promote the differentiation of gran-
ulocytes. Furthermore, NEAT1 can also mediate the
stress response [60].
HOXA-AS2
HOXA cluster antisense RNA 2 (HOXA-AS2) is a long
intergenic ncRNA between and antisense to the HOXA3
and HOXA4 genes in the HOXA cluster. This transcript
is expressed in NB4 PML cells and human peripheral
blood neutrophils. The current results indicate that
HOXA-AS2 plays a role in regulating cell survival through
suppressing apoptosis. In NB4 cells stimulated with all
trans retinoic acid (ATRA), the expression of HOXA-AS2
is dramatically up-regulated, and in primary peripheral
blood neutrophils, HOXA-AS2 expression is induced by
interferon gamma (IFN-γ) and TNF-α. During the prolifer-
ation of NB4 cells, the number of viable cells is decreased
post HOXA-AS2 knockdown by shRNA, while the propor-
tion of apoptotic cells is increased. The increase in death of
HOXA-AS2 knockdown cells is accompanied by elevated
TNF-related apoptosis-inducing ligand (TRAIL) levels, but
ATRA-induced NB4 cells treated with TRAIL do not show
an increase in HOXA-AS2 expression. These results dem-
onstrate that ATRA induction of HOXA-AS2 inhibits
ATRA-induced apoptosis, possibly through a TRAIL-
mediated pathway. HOXA-AS2-mediated negative regula-
tion thus contributes to the fine-tuning of apoptosis during
ATRA-induced myeloid differentiation in NB4 cells [61].
PVT1
The lncRNA PVT1 is located on chromosome 8q24, a
location shared with the well-known oncogene c-myc.
Chromosome 8q24 has an equivalent in mice (chromosome
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15), which is the most commonly recurring abnormality in
PML-RARα transgenic mice, and it cooperates with PML-
RARα to accelerate the development of myeloid leukemia.
By comparing PVT1 expression in granulocytes from
healthy donors and APL patients, it has been shown that
PVT1 is significantly up-regulated in APL patient samples.
In the process of ATRA-induced granulocytic differenti-
ation, treatment of APL cells with ATRA represses both
PVT1 expression and the expression of c-myc mRNA,
while knockdown of MYC in NB4 cells leads to PVT1
down-regulation. These data suggest that PVT1 may be
regulated by MYC and is involved in the proliferation of
APL cells. Further investigations have revealed that PVT1
knockdown has no effect on c-myc RNA but leads to the
suppression of the MYC protein level in NB4 cells. At the
same time, NB4 cells with PVT1 knockdown have a lower
survival rate than those in the control group, which sug-
gests that knockdown of PVT1 impairs the proliferation of
APL cells [62].
EGO
Eosinophil granule ontogeny (EGO) is an intronic
lncRNA derived from the inositol trisphosphate receptor
type 1 (ITPR1) gene locus. EGO is a conserved primary
transcript among humans, mice, and chickens. This
lncRNA is up-regulated with the maturation of eosino-
phils. Biochemical experiments have indicated that EGO
is non-coding because it is not associated with ribo-
somes and has no conserved open reading frames
(ORFs). Interestingly, a loss-of-function study suggested
that knockdown of EGO compromises the expression of
several proteins that are important for eosinophil devel-
opment, such as major basic protein and eosinophil-
derived neurotoxin, revealing the functional importance
of EGO in eosinophilopoiesis [63].
Morrbid
Precise regulation to the lifespan of neutrophils, eosino-
phils, and “classical” monocytes is important for enhan-
cing immune responses against chronic inflammation. It
has recently been confirmed that a lncRNA, termed
myeloid RNA regulator of Bim-induced death (Morrbid),
mediates the survival of neutrophils, eosinophils, and
classical monocytes in response to pro-survival cyto-
kines. Morrbid is a conserved transcript across species,
contains five exons, and is polyadenylated. It is localized
predominately in the nucleus bound to chromatin.
Morrbid is highly and specifically expressed by mature
eosinophils, neutrophils, and classical monocytes in both
mice and humans. Morrbid regulates the lifespan of
eosinophils, neutrophils, and monocytes through pro-
moting the enrichment of the PRC2 complex at the
promoter of Bcl2L11 (Bim), a neighboring pro-apoptotic
gene of Morrbid, and in turn, accelerating the deposition
of H3K27-me3 to maintain this gene in a poised state.
This Morrbid-regulated process occurs in cis, enabling
allele-specific control of Bcl2L11 transcription. Thus, in
these highly inflammatory cells, changes in Morrbid levels
provide a locus-specific regulatory mechanism that allows
for rapid control of apoptosis in response to extracellular
pro-survival signals. Additionally, Morrbid may be a po-
tential therapeutic target for the treatment of inflamma-
tory disorders characterized by aberrant short-lived
myeloid cell lifespan because it is dysregulated in patients
with hypereosinophilic syndrome [64].
LncRNAs in monocytes and macrophages
Monocyte-macrophages are crucial for the modulation
of physiological and pathological processes such as in-
flammation, tissue damage and repair, metabolism,
and pathogen response. Monocytes derived from bone
marrow migrate to tissues and organs along with blood
circulation and then develop into macrophages. Macro-
phages are able to differentiate and polarize into the clas-
sically activated M1 phenotype or alternatively activated
M2 phenotype. Generally, M1 macrophages play import-
ant roles in host defense and inflammation, while M2
macrophages play a part in tissue repair [65]. M1 and M2
show distinct gene profiles that are regulated by specific
signaling cascades, TFs, and epigenetic factors [66].
Currently, a variety of lncRNAs have been demonstrated
to impair the function and development of monocyte-
macrophages.
PACER
In the PMA-induced human monocyte-macrophage
differentiation system, it is demonstrated that PACER,
an antisense long ncRNA located in the nucleus, is
expressed in the upstream region of COX-2. CTCF/
cohesin promotes PACER expression by establishing a
chromatin domain characterized by increased H3K4
methylation and H4K8 acetylation and decreased H4K20
trimethylation, thus forming a permissive chromatin en-
vironment and protecting the COX-2 regulatory region
from surrounding repressive chromatin. COX-2 expres-
sion is accelerated by PACER in PMA-driven human
monocyte-macrophage differentiation with subsequent
LPS stimulation through diverse mechanisms. It has been
shown that lncRNA PACER is capable of sequestering the
repressive NF-kB p50 homodimer from binding to the
promoter of COX-2 and facilitating the formation of the
active p50–p65 form of NF-kB in the promoter region of
COX-2. At the same time, PACER enhances recruitment
of the p300 histone acetyltransferase (HAT) and RNAP II
pre-initiation complex to increase histone acetylation and
induce COX-2 transcription [67].
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Lnc-MC
A long non-coding monocytic RNA (lnc-MC) exhibits
increased expression during the differentiation from
monocyte to macrophage of THP-1 and HL-60 cells as
well as CD34+ hematopoietic stem/progenitor cells
(HSPCs). Lnc-MC is transcriptionally activated by PU.1
which can weaken the repressive effect of miR-199a-5p
on lnc-MC expression and function as well as promote
the monocyte/macrophage differentiation. Lnc-MC fa-
cilitates the monocyte/macrophage differentiation of
THP-1 cells and CD34+ HSPCs through sequestering
miR-199a-5p and alleviating repression on the expres-
sion of activin A receptor type 1B (ACVR1B) which is a
key regulator of monocyte/macrophage differentiation.
Thus, the two PU.1-regulated ncRNAs, lnc-MC and
miR-199a-5p, have opposing roles in monocyte/macro-
phage differentiation [68].
LincRNA-Cox2
In mouse macrophages, lincRNA-Cox2 is located 50-kb
downstream from the Cox2 (Ptgs2) gene appearing in
both the cytosolic and nuclear compartments and its ex-
pression is induced by TLR ligands in a MyD88- and
NF-kB-dependent manner. LincRNA-Cox2 has been shown
to inhibit expression of 787 genes in non-stimulated bone
marrow-derived macrophages (BMDMs) and increase the
expression of 713 genes in BMDM following stimulation
with the synthetic bacterial triacylated lipopeptide Pam3-
Cys-Ser-Lys4 (Pam3CSK4). Genes involved in the immune
response, such as CCL5 and interleukin (IL)-6, were shown
to be included. LincRNA-Cox2 suppresses gene expression
through interacting with hnRNP-A/B and hnRNP-A2/B1,
which are members of a family of multifunctional
RNA-binding proteins that are known to have a role in
the processing of precursor mRNA as well as in regulating
gene expression [69]. A recent study has indicated that in
intestinal epithelial cells, lincRNA-Cox2 mediates the tran-
scription of IL-12b induced by TNF-a through modulating
Mi-2/NuRD-mediated epigenetic histone modification
[70]. As the most highly TLR ligand-induced lincRNA in
macrophages, lincRNA-Cox2 has recently been found to
be an early-primary inflammatory gene regulated by NF-kB
signaling in murine macrophages. After macrophages are
stimulated by LPS, lincRNA-Cox2 is assembled into the
switch/sucrose non-fermentable (SWI/SNF) complex
which is capable of mediating the assembly of NF-kB
subunits to the SWI/SNF complex and ultimately,
SWI/SNF-associated chromatin remodeling and trans-
activation of the late-primary inflammatory-response
genes in macrophages in response to microbial challenge.
Therefore, this indicates a new regulatory role for NF-kB-
induced lincRNA-Cox2 acting as a coactivator of NF-kB
for the transcription of late-primary response genes in
innate immune cells through modulation of epigenetic
chromatin remodeling [71].
THRIL
It has been shown that in human THP1 macrophages,
THRIL, which has been identified as an antisense lncRNA
(overlapping BRI3BP), can up-regulate TNF transcription
through forming a complex with hnRNPL and binding to
the promoter of TNF. Pam3Csk4 decreases THRIL ex-
pression in THP1 macrophages indirectly by inducing the
release of TNFα. THRIL knockdown induces the de-
creased expression of 444 genes in THP1 macrophages. In
addition, THRIL knockdown blocks the different expres-
sion of 317 genes out of 618 genes observed in THP1
macrophages stimulated with Pam3CSK4, including mul-
tiple inflammatory genes such as IL6, CXCL8, CXCL10,
CCL1, and CSF1 [72].
Lnc-DC
By analysis of the expression profile of lncRNAs during
monocytes differentiating into dendritic cells, the level
of lnc-DC has been identified to be especially increased.
Additionally, PU.1 which is a key regulator of DC differ-
entiation induces the exclusive expression of lnc-DC in
human cDCs through binding to the promoter region.
By using chromatin ChIP-seq and multisite ChIP-qPCR,
high occupancy of Pol II along with increased histone
H3-lysine-4 trimethylation (H3K4me3) and histone H3-
lysine-27 acetylation (H3K27ac) around the lnc-DC
transcription start site (TSS) in Mo-DCs have been
identified. Lnc-DC knockdown during Mo-DC differen-
tiation decreases the expression of CD40, CD80, CD86,
and HLA-DR on the surface of cells and affects their
capacity to uptake antigen and activate CD4+ T cells,
while overexpression of lnc-DC has the opposite effect.
Lnc-DC regulates Mo-DC differentiation by directly
interacting with STAT3, which is a crucial transcription
factor of Mo-DC differentiation in cytoplasm, to prevent
Y705 dephosphorylation of STAT3 by SHP1 [73].
However, in a recent work of Dijkstra and Ballingall, it
is mentioned that the so-called mouse lnc-DC ortholog
gene in the study by Wang et al. has already been des-
ignated “Wdnm1-like” and is able to encode a small
secreted protein. Wdnm1-like is found in mammals;
however, the incapacitation of the Wdnm1-like open
reading frame is definitely rare with all investigated
primates except for hominids having an intact ORF.
Thus, it is supposed that the human lnc-DC transcript
might only represent a non-functional relatively young
evolutionary remnant of a protein-coding locus. Neverthe-
less, if the conclusions by Wang et al. on their human
model are correct, then current knowledge regarding the
Wdnm1-like locus suggests an intriguing combination of
different functions mediated by transcript and protein in
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Table 1 LncRNAs involved in the development of myeloid cells
LncRNAs Model system Observation Refs
LncRNAs in erythrocytes and megakaryocytes
LincRNA-EPS Mouse Ter119+ cells LincRNA-EPS regulates apoptosis during the terminal
differentiation of erythroid cells and blocks the proliferation
of erythroid progenitors partly through inhibiting Pycard
expression
[35, 37]
Shlnc-EC6 Erythroid progenitor and hematopoietic
stem cells (FLEPHSCs) purified from mouse
fetal liver
Shlnc-EC6 knockdown results in increased expression of Rac1
and the up-regulated activation of downstream PIP5K which
leads to the inhibition of enucleation in cultured mouse fetal
erythroblasts
[38]
AlncRNA-EC7 Differentiating mouse fetal liver red blood
cells/K562 cells
AlncRNA-EC7 mediates erythropoiesis partly by regulating
enhancer looping to activate the BAND3 locus
[39, 40]
MONC MIR100HG Cord-blood (CB) CD34+-HSPCs MONC/MIR100HG knockdown inhibits leukemic growth of
AMKL cell lines and primary patient samples; MONC interferes
with hematopoietic lineage decisions and enhances the
proliferation of immature erythroid progenitor cells
[41]
LncRNAs in granulocytes
HOTAIR Human AML cells
Lung cancer cells
HOTAIR is up-regulated in acute myeloid leukemia and that
indicates a poor prognosis; HOTAIR knockdown is capable
of inhibiting the proliferation of AML cells
[54, 55]
HOTAIRM1 ATRA-induced NB4 cells HOTAIRM1 plays a role in the myelopoiesis through
modulation of gene expression in the HOXA cluster and
integrin-controlled cell cycle progression
[50, 56]
NEAT1 Acute promyelocytic leukemia cells ATRA could not continue to promote the differentiation of
granulocytes after NEAT1 blockade
[60]
HOXA-AS2 ATRA-induced NB4 cells HOXA-AS2-mediated negative regulation thus contributes to
the fine-tuning of apoptosis during myeloid differentiation
[61]
PVT1 ATRA-induced NB4 cells Knockdown of PVT1 leads to the suppression of the MYC
protein level and impairs the proliferation of APL cells
[62]
EGO IL-5 treated CD34+ hematopoietic
progenitors
EGO is highly expressed in mature of eosinophils; knockdown
of EGO compromises the expression of several proteins that
are important for eosinophil development
[63]
Morrbid Human/mouse neutrophils, eosinophils
and monocytes
Morrbid integrates extracellular signals to control the lifespan
of eosinophils, neutrophils, and monocytes through allele-
specific suppression of Bcl2l11
[64]
LncRNAs in monocytes and macrophages
PACER PMA- and LPS-stimulated human U937
monocytic cell line
PACER is expressed upstream of the Cox2 promoter and
positively regulates COX2 production; PACER binds to and
drives the release of the repressive p50 dimer of NF-kB from
the Cox2 promoter
[67]
Lnc-MC Differentiation from monocyte tomacrophage
of THP-1, HL-60, HSPCs
Lnc-MC facilitates the monocyte/macrophage differentiation
through sequestering miR-199a-5p and alleviating repression
on the expression of ACVR1B
[68]
LincRNA-Cox2 Pam3CSK 4-stimulated mouse bone
marrow-derived macrophages
LincRNA-Cox2 suppresses gene expression through
interacting with hnRNP-A/B and hnRNP-A2/B1, modulating
histone modification and epigenetic chromatin remodeling
[70, 71]
THRIL Pam3CSK 4 -stimulated human THP1 macrophages THRIL knockdown blocks the different expression of multiple
inflammatory genes in THP1 macrophages stimulated with
Pam3CSK4
[72]
Lnc-DC Differentiation of human and mouse dendritic cells Lnc-DC promotes phosphorylation and activation of STAT3




Mouse/human bone marrow macrophages LncRNA E330013P06 is significantly up-regulated in M2
macrophages and its overexpression induces the expression
of pro-inflammatory and pro-atherogenic genes in
macrophages
[74]
TCONS_00019715 Human monocyte-derived macrophages (MDMs)
polarized towards M(IFN-γ+ LPS) or M(IL-4) phenotypes
TCONS_00019715 knockdown down-regulates the expression
of M(IFN-γ + LPS) markers and promotes the expression of
M(IL-4) markers in THP-1 cells induced by IFN-γ and LPS
[75]
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the maturation of several cell types at some point in
evolution [74].
LncRNA-E330013P06
As is known, macrophages mediate the accelerated in-
flammation associated with diabetes complications.
Nevertheless, the specific molecular mechanisms are still
unknown. In a study by Reddy et al, RNA sequencing
was used to detect the transcripts of bone marrow mac-
rophages isolated from diabetic db/db mice and control
db/+ mice. The RNA sequencing results indicated that
diabetes promotes the polarization of macrophages into
M2, which is a pro-inflammatory, pro-fibrotic, and dys-
functional alternatively activated macrophage phenotype,
through TFs associated with macrophage function. Bio-
informatics analysis of RNA-seq data identify that dia-
betes can change the expression of several long ncRNAs.
Among these lncRNAs, lncRNA E330013P06 is signifi-
cantly up-regulated in M2 macrophages. Furthermore,
human lncRNA E330013P06 genomic organization is
similar to the mouse gene and is a host gene for miR-143
and miR-145 which are implicated in cancer, vascular dis-
ease, and insulin resistance. It is supposed that sustained
overexpression of lncRNA E330013P06 induces the ex-
pression of pro-inflammatory and pro-atherogenic genes,
such as IL-6, CCL2, CD36, and PTGS2, in macrophages,
enhances responses to inflammatory signals, and pro-
motes foam cell formation. However, silencing lncRNA
E330013P06 inhibits the expression of inflammatory genes
induced by diabetic stimulation. These results confirm the
crucial functional roles for lncRNA E330013P06 in macro-
phages [66].
TCONS_00019715
In a recent work, by using a microarray, researchers
have detected the expression profile of lncRNAs in hu-
man monocyte-derived macrophages (MDMs) polar-
ized towards M(IFN-γ + LPS) or M(IL-4) phenotypes.
When compared to primary MDMs, expression of 9343
lncRNAs and 4592 lncRNAs are deregulated in the
M(IFN-γ + LPS) and M(IL-4) groups, respectively. The
following RT-qPCR data are similar to the microarray
results. Furthermore, the expression of lncRNA
TCONS_00019715 in M(IFN-γ + LPS) macrophages is
found to be much higher than in M(IL-4) macrophages.
Additionally, the level of TCONS_00019715 is appar-
ently increased when M(IL-4) is converted to M(IFN-γ +
LPS), while it is decreased when M(IFN-γ + LPS) is con-
verted to M(IL-4). TCONS_00019715 knockdown down-
regulates the expression of M(IFN-γ + LPS) markers and
promotes the expression of M(IL-4) markers in THP-1
cells induced by IFN-γ and LPS. These data show
Table 2 The expressing stage and associated clinical studies of lncRNAs
LncRNAs Expressing stage Clinical study Refs
LncRNAs in erythrocytes and megakaryocytes
LincRNA-EPS Terminal erythrocyte – [35, 37]
Shlnc-EC6 Erythroid progenitors – [38]
AlncRNA-EC7 Erythroid progenitors – [39, 40]
MONC/MIR100HG Erythroid precursors Acute megakaryoblastic leukemia [41]
LncRNAs in granulocytes
HOTAIR Progranulocytes Acute myelocytic leukemia Lung cancer [54, 55]
HOTAIRM1 Neutrophils – [50, 56]
NEAT1 Progranulocytes Acute promyelocytic leukemia [60]
HOXA-AS2 Progranulocytes/Neutrophils – [61]
PVT1 Progranulocytes Acute promyelocytic leukemia [62]
EGO Eosinophils – [63]
Morrbid Neutrophils/eosinophils/monocytes Hypereosinophilic syndrome [64]
LncRNAs in monocytes and macrophages
PACER Monocytes – [67]
Lnc-MC Monocytes/macrophages – [68]
LincRNA-Cox2 Macrophages – [70, 71]
THRIL Macrophages – [72]
Lnc-DC DCs – [73]
LncRNA-E330013P06 M2 macrophages – [66]
TCONS_00019715 M1 macrophages – [75]
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lncRNAs play important roles in regulating macrophage
polarization [75].
Conclusions
In the cell fate of myeloid cells, abundant transcriptional
factors (TFs) have been demonstrated to play significant
roles, creating a complicated regulation network con-
structed from progenitors to differentiated blood cells.
In recent years, with the redefinition and investigation of
ncRNAs, long ncRNAs have emerged as essential modu-
lators of cellular biology via various mechanisms. How-
ever, the investigation of lncRNAs is associated with
great challenges due to the large profiling list and low
evolutionary sequence conservation of lncRNAs. In this
review, we focus on the regulation of lncRNAs in the
development of myeloid cells (Tables 1 and 2). As
summarized above, lncRNAs are closely involved in the
development of erythrocytes, megakaryocytes, granulo-
cytes, monocytes, and macrophages via diverse regulatory
mechanisms (Fig. 1). Among these mechanisms, lncRNAs,
acting as endogenous miRNA sponges or competing
endogenous RNAs (ceRNAs), are attracting more and
more attention which is helpful in characterizing the
function of these RNA transcripts. All of these findings
make lncRNAs great candidates for participating in finely
tuned regulation in the development of myeloid cells.
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